Connectus Wealth’s Eli Lilly LLY Stock Holding History

Connectus Wealth’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$6.6M	Sell	8,487 -5,920	-41%	-$4.21M	0.18%	109
2023 Q4	$8.4M	Sell	14,407 -1,441	-9%	-$841K	0.17%	123
2023 Q3	$8.52M	Buy	15,848 +4,972	+46%	+$2.56M	0.19%	118
2023 Q2	$5.1M	Buy	10,876 +2,428	+29%	+$1.02M	0.12%	138
2023 Q1	$2.9M	Sell	8,448 -649	-7%	-$219K	0.07%	190
2022 Q4	$3.33M	Sell	9,097 -583	-6%	-$207K	0.08%	167
2022 Q3	$3.13M	Buy	9,680 +12	+0.1%	+$3.8K	0.07%	222
2022 Q2	$3.14M	Buy	9,668 +3,614	+60%	+$1.08M	0.07%	174
2022 Q1	$1.67M	Sell	6,054 -6,343	-51%	-$1.63M	0.05%	179
2021 Q4	$3.43M	Buy	+12,397	New	+$3.14M	0.13%	97

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Connectus Wealth's LLY Position: Q1 2024 in Review

Connectus Wealth reduced its Eli Lilly (LLY) stake by 41% in Q1 2024, selling an estimated $4.21M and leaving 8,487 shares worth $6.6M. The position accounts for 0.18% of the portfolio, ranked #109.

Connectus Wealth first reported a position in LLY in Q4 2021 and has held it in 10 quarters since. The position peaked at $8.52M in Q3 2023. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

Connectus Wealth held 8,487 shares of Eli Lilly worth $6.6M as of Q1 2024.
Connectus Wealth sold 5,920 Eli Lilly shares in Q1 2024, an estimated $4.21M.
Eli Lilly made up 0.18% of Connectus Wealth's portfolio in Q1 2024, its #109 holding.
Connectus Wealth first reported a position in Eli Lilly in Q4 2021 and has held it in 10 quarters since.
Connectus Wealth's Eli Lilly position peaked at $8.52M in Q3 2023.
3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.